CD34+CELLS IN BONE MARROW IN 272 MYELODYSPLASIC SYNDROMES WITHOUT MODIFIER TREATMENT: ADDED VALUE TO IPSS-R IN PREDICTION OF LEUKEMIC PROGRESSION

HAEMATOLOGICA(2017)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要